The Largest Companies in Laboratory Analytical Instruments Industry Value and Market Capitalization, Revenue, Income, Number of Employees - CSIMarket
Healthcare Sector

The Largest Companies in Laboratory Analytical Instruments Industry

Explore the largest companies by market capitalization, revenue, income, and employees within the Laboratory Analytical Instruments industry

Classification: SIC NAICS ISIC Available under Commercial License
TTM data as of: September 28, 2026
Total Market Cap
$ 228B
Billions USD (aggregate)
Total Revenue (TTM)
$ 38B
Trailing twelve months
Total Net Income (TTM)
$ 2B
Trailing twelve months
Total Employees
93,436
Headcount (aggregate)
API endpoints for this dataset
https://api.csimarket.com/api/v1/industries/806/list
Programmatic access for models, analytics, and integration workflows.

Explore the largest companies by market capitalization, revenue, income, and employees within the Laboratory Analytical Instruments industry

Company Market Cap
(Millions)
Revenue TTM
(Millions)
Net Income TTM
(Millions)
Employees
Total Laboratory Analytical Instruments Industry $ 227,604 $ 38,114 $ 2,026 93,436
30 more companies available

Sign in to unlock the full Laboratory Analytical Instruments Industry dataset.

Industry Benchmarking Dataset for Institutional Use

Commercial

The data presented above is part of our institutional-grade Industry Benchmarking Dataset, designed for integration into credit risk models, AML/KYC frameworks, portfolio analytics, and internal banking systems. The full dataset is available under a Commercial License, with delivery via API or bulk CSV datasets.

Advanced Metrics & Analytics
  • Multi-year CAGRs & growth acceleration signals
  • Volatility measures & trend stability indicators
  • Cross-sectional percentiles (median, p25, p75)
  • Dispersion metrics (std deviation, spread)
  • Composite scores (growth quality, distress risk)
Institutional Use Cases
  • Credit underwriting & peer benchmarking
  • AML / KYC financial validation
  • Portfolio monitoring & risk tracking
  • Quantitative modeling & factor construction
  • Sector risk & supply chain exposure analysis
Data Delivery
API Access
Real-time endpoints delivering data into risk engines, models, and internal systems.
Bulk CSV Datasets
Pre-structured datasets optimized for direct ingestion into data warehouses, enabling large-scale modeling, backtesting, and historical analysis.
Licensing
Available under institution-grade licensing frameworks with defined usage rights, distribution scope, and integration permissions, supporting internal use, client reporting, and enterprise-wide deployment.
CSIMarket - Industry Benchmarking Data - Per Industry

Institutional-grade industry datasets
in standardized CSV format

Pre-cleaned, audit-ready benchmarking data for this industry - 6 CSV files covering profitability, growth, valuation, efficiency, management effectiveness, and financial strength. Each file delivers 20 quarters and 5 fiscal years of history, with statistical distributions and composite scores per period.

6CSV files
3,880Quarterly endpoints
360Annual endpoints
20Quarters of history
5Fiscal years
Profitability
37 quarterly - 10 annual indicators 790 endpoints ?
Growth
31 quarterly - 7 annual indicators 1,455 endpoints ?
Valuation
29 quarterly - 10 annual indicators 630 endpoints ?
Efficiency
16 quarterly - 12 annual indicators 380 endpoints ?
Management
20 quarterly - 16 annual indicators 480 endpoints ?
Fin. Strength
21 quarterly - 17 annual indicators 505 endpoints ?
Total dataset size - across 110 industries
Quarterly data points
388,000
3,880 × 110 industries
Annual data points
36,000
360 × 110 industries
Industries covered
110
all sectors
Total data points
424,000
quarterly + annual
Industry classification systems supported
CSIMarket Proprietary classification optimized for financial benchmarking and industry analytics
NAICS North American Industry Classification System - used by U.S., Canada & Mexico federal agencies
SIC Standard Industrial Classification - legacy system used by the SEC and financial regulators
ISIC International Standard Industrial Classification - UN framework for global economic comparison
Dataset 1 - Profitability Benchmarks

Margin benchmarks across the full industry distribution

Gross, operating, EBITDA, pre-tax, net, and free cash flow margins - delivered as TTM, quarterly, and annual series with P25 / median / P75 / standard deviation for every reporting period.

Net margin (TTM Q4)
7.44%
+2.11pp vs prior yr
Gross margin
10.44%
industry avg
FCF margin
13.66%
strong
Companies reported
31
Q4 2025
Data coverage per industry
Quarterly indicators
37
metrics per period
Annual indicators
10
fiscal year metrics
Quarterly endpoints
740
20 quarters × 37
Annual endpoints
50
5 fiscal years × 10
Gross, operating, EBITDA, net & FCF margins
TTM, quarterly & fiscal year series
P25 / median / P75 / std dev per period
YoY margin change & acceleration
Effective tax rate & pre-tax margin
Profitability composite score (0–100)
Report preview - Profitability Benchmarks - Aerospace & Defense
Profitability Benchmarks report sample
Dataset 2 - Growth Dynamics

Revenue, income & cash flow growth across 13+ line items

Industry-level growth benchmarks for every major P&L and cash flow line - with breadth indicators showing what share of companies posted positive growth, acceleration metrics, and rolling TTM comparisons.

Revenue growth (TTM Q4)
12.84%
improving
Net income growth
18.45%
above revenue
FCF growth
13.60%
strong
EPS acceleration
+3.69pp
vs prior TTM
Data coverage per industry
Quarterly indicators
31
metrics per period
Annual indicators
7
fiscal year metrics
Quarterly endpoints
1,420
20 quarters × 31
Annual endpoints
35
5 fiscal years × 7
Revenue, gross, EBIT & operating income growth
Net income, EPS (basic & diluted) growth
FCF, net cash flow & CapEx growth
Breadth: % of companies with positive growth
QoQ, YoY, TTM & 3-year CAGR
Growth composite score (0–100)
Report preview - Growth Dynamics - Aerospace & Defense
Growth Dynamics report sample
Dataset 3 - Valuation Multiples

Industry valuation multiples with 5-year context & Z-scores

P/E, P/S, P/FCF, P/Book, EV/EBITDA - current and trailing - with five-year averages, percentile ranks, Z-scores, and a composite valuation score to place the industry in historical context.

P/E ratio (current)
22.4x
vs 5yr avg 14.2x
EV/EBITDA (TTM)
13.1x
P25–P75: 4.5x–20.4x
Earnings yield
4.46%
attractive
Composite val. score
61.7
moderately valued
Data coverage per industry
Quarterly indicators
29
metrics per period
Annual indicators
10
fiscal year metrics
Quarterly endpoints
580
20 quarters × 29
Annual endpoints
50
5 fiscal years × 10
P/E, P/S, P/CF, P/FCF, P/Book multiples
EV/EBITDA & EV/Sales (current & TTM)
5-year historical average per multiple
Z-scores & percentile ranks
Earnings yield & FCF yield
Composite valuation score (0–100)
Report preview - Valuation Multiples - Aerospace & Defense
Valuation Multiples report sample
Dataset 4 - Operational Efficiency

Productivity, turnover ratios & cash conversion benchmarks

Revenue and income per employee, asset and receivables turnover, days sales outstanding, days inventory, days payables, and the full cash conversion cycle - benchmarked across the industry distribution.

Revenue / employee
$487K
improving
Asset turnover
0.61x
P75: 0.80x
Cash conv. cycle
113 days
above avg
Efficiency score
68.7
composite 0–100
Data coverage per industry
Quarterly indicators
16
metrics per period
Annual indicators
12
fiscal year metrics
Quarterly endpoints
320
20 quarters × 16
Annual endpoints
60
5 fiscal years × 12
Revenue & net income per employee
Asset, receivables & inventory turnover
DSO, DIO, DPO & cash conversion cycle
Working capital per revenue
YoY & TTM trend for all metrics
Efficiency composite score (0–100)
Report preview - Operational Efficiency - Aerospace & Defense
Operational Efficiency report sample
Dataset 5 - Management Effectiveness

ROA, ROE, ROIC & DuPont decomposition benchmarks

Return metrics measuring how effectively management allocates capital - with incremental ROIC, DuPont decomposition, FCF quality indicators, and a composite management effectiveness score across the industry.

Return on assets
5.05%
vs 4.44% prior
Return on equity
14.22%
improving
ROIC (TTM)
9.77%
P75: 12.4%
Effectiveness score
72.4
composite index
Data coverage per industry
Quarterly indicators
20
metrics per period
Annual indicators
16
fiscal year metrics
Quarterly endpoints
400
20 quarters × 20
Annual endpoints
80
5 fiscal years × 16
ROA, ROE & ROIC - TTM & quarterly
Incremental ROIC & capital intensity
DuPont 3-factor decomposition
FCF conversion quality metrics
P25 / median / P75 / std dev per metric
Management effectiveness composite (0–100)
Report preview - Management Effectiveness - Aerospace & Defense
Management Effectiveness report sample
Dataset 6 - Financial Strength

Leverage, liquidity & debt coverage across the industry

Debt-to-equity, interest and debt coverage, quick ratio, working capital, leverage ratios - full distribution statistics - in standardized, audit-ready format suited for credit workflows, compliance, and ESG reporting.

Debt / equity (TTM)
1.44x
above industry avg
Interest coverage
8.32x
comfortable
Quick ratio
0.91x
vs P75 1.18x
Fin. strength score
58.4
composite 0–100
Data coverage per industry
Quarterly indicators
21
metrics per period
Annual indicators
17
fiscal year metrics
Quarterly endpoints
420
20 quarters × 21
Annual endpoints
85
5 fiscal years × 17
Quick ratio & working capital ratio
Total & LT debt-to-equity
Leverage & tangible leverage ratios
Interest & debt coverage ratios
P25 / median / P75 / std dev per metric
Financial strength composite score (0–100)
Report preview - Financial Strength - Aerospace & Defense
Financial Strength report sample
Methodology
1. Data Coverage & Universe
Structured dataset built from publicly listed companies, classified across industries, sectors, and total market using CSIMarket, NAICS, SIC, and ISIC frameworks.

Includes up to 5 years of quarterly data (TTM, quarterly, annualized) with continuous updates during earnings cycles.

Coverage transparency includes total companies, reported companies per metric, and coverage ratios.
2. Aggregation Methodology
Industry metrics are calculated using aggregated financial statements, not averages.

Sum-based aggregation is applied to revenue, income, assets, and debt, with market-cap weighting for valuation metrics and TTM normalization to reduce seasonality.

Example: P/E = Total Market Cap ÷ Total Net Income.
3. Ratio Construction
Ratios are standardized and calculated at the company level, then benchmarked across industries.

Covers profitability, valuation, financial strength, efficiency, and growth metrics including margins, ROE, EV multiples, leverage ratios, and CAGR growth measures.
4. Distribution Analytics
Full cross-sectional distribution analysis includes median (P50), quartiles (P25/P75), standard deviation, and interquartile range.

Enables detection of outliers, dispersion, and structural differences within industries.
5. Percentile Rankings
Metrics are normalized into 0–100 percentile rankings using cross-industry PERCENT_RANK().

Direction is adjusted by metric (higher = better for growth/profitability, lower = better for leverage/risk).

Used for benchmarking, factor models, and relative analysis.
6. Volatility & Trend Metrics
Includes volatility (e.g., 8-quarter standard deviation), trend slopes, and growth consistency metrics.

Captures earnings stability, margin durability, and cyclicality across industries.
7. Composite Scores
Multi-factor composite scores (0-100 scale) combine normalized inputs using weighted models.

Includes valuation, growth quality, financial strength, and distress risk scores.
8. Data Quality Controls
Data undergoes standardization, outlier detection, consistency checks, and coverage-based filtering.

Reporting counts and coverage ratios are provided for transparency.
9. Update Frequency
Dataset is continuously updated during earnings seasons.

TTM metrics are recalculated with each new filing, reflecting the most recent reported data.
10. Use Cases
Designed for credit risk analysis, AML/KYC validation, portfolio monitoring, quantitative modeling, and benchmarking workflows.
11. Licensing & Access
Free preview available for evaluation. Full dataset access requires a commercial license.

API and bulk delivery options available for system integration.

Recent News from The Largest Companies in Laboratory Analytical Instruments Industry

Clinical Study
EyePoint Pharmaceuticals Advances DURAVYU Trials A Promising Leap Towards New Treatments for Vision Loss,

In a significant boost for the field of ophthalmology, EyePoint Pharmaceuticals has announced a positive recommendation from the Independent Data Safety Monitoring Committee (DSMC) regarding its pivotal Phase 3 trials for DURAVYU, specifically targeting the treatment of wet age-related macular degeneration (wet AMD). The favorable review was provided for ...

Nov 19, 2025 • Laboratory Analytical Instruments Industry
EYPT
Business Update
Revvity Expands Scientific Software Capabilities and Genomic Diagnostic Solutions Through Strategic Acquisitions and ...

Revvity’s Strategic Moves to Enhance Scientific Software and Genomic Diagnostics WALTHAM, Mass. In an ambitious bid to bolster its position in the analytical and genomic landscapes, Revvity, Inc. (NYSE: RVTY), has announced significant operational advancements through targeted acquisitions and strategic collaborations. The company is steadfastly commi...

Nov 10, 2025 • Laboratory Analytical Instruments Industry
RVTY
Clinical Study
Unraveling the Proteome Seer’s Proteograph Platform Propels Biomedical Discovery to New Heights

In the realm of modern medicine, where the intricate web of biological processes governs health and disease, the need for holistic approaches to understanding human biology is paramount. At the recent Human Proteome Organization (HUPO) 2025 conference, Seer and its esteemed collaborators unveiled groundbreaking new data demonstrating the translational pot...

Nov 7, 2025 • Laboratory Analytical Instruments Industry
SEER
Announcement
Navigating Turbulence The Legal and Financial Struggle of Avantor, Inc.,

The Growing Legal Battle Surrounding Avantor, Inc.: A Comprehensive Look CSIMarket.com In the realm of public investment, few scenarios create as much stir as a class action lawsuit against a major corporation. Such is the case with Avantor, Inc., a prominent player in the healthcare sector, now facing a class action lawsuit as announced by the Portn...

Nov 6, 2025 • Laboratory Analytical Instruments Industry
AVTR
Clinical Study
Unraveling Genomic Complexity HiFi Genomes Bridge Research and Clinical Applications

The landscape of genomic research is evolving rapidly, particularly with regard to the need for precision and accuracy in identifying clinically relevant genetic variants. A recent multi-center study has demonstrated the capabilities of Pacific Biosciences’ (PacBio) HiFi genome sequencing technology, establishing its potential value in both research an...

Nov 6, 2025 • Laboratory Analytical Instruments Industry
PACB
Announcement
Avantor, Inc. Faces Investor Class Action Amid Troubling Financial Declines A Legal and Economic Analysis,

Los Angeles In an unfolding legal drama, Avantor, Inc. (NYSE: AVTR), a global leader in providing mission-critical products and services to customers in life sciences and advanced technologies, finds itself at the center of a class action lawsuit. The Portnoy Law Firm, located in Los Angeles, has announced a suit on behalf of investors who purchased Ava...

Nov 5, 2025 • Laboratory Analytical Instruments Industry
AVTR
Partnership
A Milestone in Genomic Medicine PacBio and Berry Genomics Pioneer Long-Read Sequencing in China

In a transformative stride toward advancing genomic medicine, PacBio has partnered with Berry Genomics to secure the first regulatory approval for clinical long-read sequencing in China. The National Medical Products Administration (NMPA) has officially granted approval for the Sequel II CNDx system, a revolutionary platform that leverages PacBio s High-F...

Nov 4, 2025 • Laboratory Analytical Instruments Industry
PACB
Business Update
Navigating Dual Currents Revvity Set for Key Investor Conferences Amid Market Challenges,

In the ever-evolving landscape of healthcare technology, Revvity, Inc. (NYSE: RVTY), headquartered in Waltham, Massachusetts, is set to make a noteworthy appearance at several prestigious investor conferences in the coming months. The company has announced that Max Krakowiak, its senior vice president and chief financial officer, will present at the UBS G...

Oct 29, 2025 • Laboratory Analytical Instruments Industry
RVTY
Business Update
Revvity Innovates with Strategic Advances in AI-Enhanced Gene Editing, Automated Specialty Testing, and TB Detection

Revvity s Latest Developments: Enhancing Precision in Healthcare WALTHAM, Mass. Revvity, Inc. (NYSE: RVTY) stands at the forefront of biotechnology innovation with a series of strategic advances aimed at enhancing the precision and efficiency of healthcare technologies. AI-Enhanced Base Editing Collaboration with Profluent Revvity recently announced a str...

Sep 22, 2025 • Laboratory Analytical Instruments Industry
RVTY
Product Service News
CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Geneti...

Pioneering a New Era: Bionano Genomics OGM Receives Preliminary CMS Payment DeterminationIn a significant development for genomic medicine, Bionano Laboratories, a subsidiary of Bionano Genomics, Inc. (NASDAQ: BNGO), announced on September 15, 2025, that the Centers for Medicare and Medicaid Services (CMS) has published a preliminary payment determinati...

Sep 15, 2025 • Laboratory Analytical Instruments Industry
BNGO
Product Service News
Game, Set, Match How Aryna Sabalenka’s US Open Triumph Serves Up Success for Prenetics,

In an era where sports and health intersect increasingly, Prenetics Global Limited (NASDAQ: PRE), a frontrunner in health sciences, finds itself in the spotlight, thanks to its celebrated global ambassador and shareholder World No. 1 tennis player Aryna Sabalenka. The company recently congratulated Sabalenka on her impressive feat: defending her singles ...

Sep 9, 2025 • Laboratory Analytical Instruments Industry
PRE
Partnership
Unraveling the Epigenetic Code PacBio and EpiCypher Pioneering a New Era in Genetic Research

In an era where the intricacies of genetics unravel myriad pathways leading to our understanding of health and disease, Pacific Biosciences of California Inc. (PacBio) has forged a strategic partnership with EpiCypher, a leap that promises to illuminate the shadows in epigenomics. This collaboration, featuring the Fiber-seq workflow, represents a signific...

Sep 3, 2025 • Laboratory Analytical Instruments Industry
PACB
Business Update
Agilent Technologies Inc. (NYSE A), a globally recognized leader in life sciences, diagnostics, and applied...

Agilent Technologies Strengthens Its Position as a Leader in Analytical Solutions with New Product Launches at Upcoming European Congresses Agilent Technologies Inc. (NYSE: A), a globally recognized leader in life sciences, diagnostics, and applied chemical markets, has recently announced its significant presence at two forthcoming prominent European cong...

Sep 3, 2025 • Laboratory Analytical Instruments Industry
A
Contract
Precipio Terminates ATM Management Decision to Reinforce Commitment to Responsible Capital Management

In a significant move reflecting its strategic financial approach, Precipio Inc. announced the termination of its Automated Teller Machine (ATM) management decision. This decision is aligned with the company’s commitment to responsible capital management, reinforcing its dedication to maintaining a robust financial framework amidst a challenging economi...

Sep 2, 2025 • Laboratory Analytical Instruments Industry
PRPO
Business Update
New Breakthroughs and Market Dynamics Navigating Agilent Technologies’ Growth Amid Challenges

Agilent Technologies Inc. (NYSE: A) has recently achieved a significant milestone, announcing that its MMR IHC Panel pharmDx (Dako Omnis) has received Class C companion diagnostic certification under the EU In Vitro Diagnostic Regulation (IVDR). This certification marks a crucial step in the diagnosis of mismatch repair (MMR) deficient colorectal cancer (...

Sep 2, 2025 • Laboratory Analytical Instruments Industry
A
Business Update
Quanterix Achieves Milestone New York State Permit Paves the Way for Precision Medicine Breakthroughs,

Unlocking New Frontiers in Precision Medicine: Quanterix Accelerator Laboratory Secures Prestigious New York State Permit In a groundbreaking development poised to revolutionize the field of biomarker research, Quanterix Corporation (NASDAQ: QTRX) today proudly announced that its Quanterix Accelerator Laboratory has been awarded a coveted clinical laborat...

Aug 22, 2025 • Laboratory Analytical Instruments Industry
QTRX
Business Update
Brukers Strategic Contracts and Market Resilience in a Tumultuous Landscape

In a notable advancement for Bruker Corporation, the company has secured several multi-year contracts valued at over $27 million, specifically for its explosives and chemical trace detection solutions within the aviation and defense sectors. These agreements, finalized throughout 2025, represent a strategic initiative to bolster the capabilities of custom...

Aug 6, 2025 • Laboratory Analytical Instruments Industry
BRKR
Business Update
Mettler-Toledo Strives for Stability Amidst Market Turbulence Ahead of Key Conference,

Mettler-Toledo Navigates Market Volatility Ahead of Healthcare Conference As Mettler-Toledo International Inc. (NYSE: MTD) prepares to deliver a webcast presentation at the BofA Securities 2025 Healthcare Conference, the company finds itself in a volatile market environment. Mettler-Toledo s current share price is $1,061.79, reflecting a period of underpe...

Apr 26, 2025 • Laboratory Analytical Instruments Industry
MTD
Dividend
Revvity Declares Quarterly Dividend, Emphasizing Commitment to Innovation and Shareholder Value in Health Sciences,

Revvity Declares Quarterly Dividend: A Sign of Steady Progress in Health SciencesWALTHAM, Mass. In a notable development for investors and stakeholders alike, the Board of Directors of Revvity (NYSE: RVTY) announced today the declaration of a regular quarterly dividend of $0.07 per share of common stock. This dividend will be payable on August 8, 2025, ...

Apr 25, 2025 • Laboratory Analytical Instruments Industry
RVTY
Management Announcement
Amidst Financial Hurdles, Bionano Genomics Pioneers Optical Genome Mapping as an Innovative Solution for Genetic Diagnostics,

IntroductionBionano Genomics, Inc. (Nasdaq: BNGO) has made significant strides in the field of genetic diagnostics with its innovative Optical Genome Mapping (OGM) technology. Recent peer-reviewed publications highlight OGM s accuracy and cost-effectiveness in identifying and sizing large repeat expansions associated with numerous genetic disorders. Howev...

Apr 23, 2025 • Laboratory Analytical Instruments Industry
BNGO
Business Update
Brukers Balancing Act Groundbreaking Scientific Innovation Meets Financial Hurdles,

Bruker Corporation Pushes Innovation Boundaries with nVista 2P, Faces Financial Challenges CSIMarket.com Bruker Corporation (Nasdaq: BRKR), a leader in scientific instrumentation, has unveiled its pioneering nVista 2P miniature two-photon microscope. Announced from San Jose, California, this state-of-the-art device represents a major advancement in the...

Apr 18, 2025 • Laboratory Analytical Instruments Industry
BRKR
Business Update
Bruker Deepens Diagnostic Expertise with Strategic Stake in Germanys RECIPE,

In a strategic move to enhance its diagnostic capabilities, Bruker Corporation (NASDAQ: BRKR) has announced a majority investment in RECIPE Chemicals + Instruments GmbH. Based in Munich, Germany, RECIPE is a recognized leader in the production of mass spectrometry-based diagnostic assay kits, primarily geared towards therapeutic drug monitoring (TDM). A S...

Apr 16, 2025 • Laboratory Analytical Instruments Industry
BRKR
Business Update
Quanterix Elevates Biomarker Detection with Groundbreaking DBS Kit Amid Regulatory Challenges

Quanterix Elevates Biomarker Detection with Groundbreaking DBS Kit Amid Regulatory Challenges In an era where precision in biomedical research is paramount, Quanterix Corporation (NASDAQ: QTRX) is making significant strides to revolutionize the field of biomarker detection. The company recently showcased its innovations at the International Conference on ...

Apr 1, 2025 • Laboratory Analytical Instruments Industry
QTRX
Product Service News
Cytek Biosciences Enhances Cell Analysis with Innovative Tools and Regulatory Advances

In a significant move that underscores its commitment to enhancing the tools for cellular analysis, Cytek Biosciences is poised to transform the field of flow cytometry with the introduction of its new Muse Micro System alongside innovative automation technology. As a company recognized for its advancements in cell analysis solutions, Cytek is set to expa...

Mar 19, 2025 • Laboratory Analytical Instruments Industry
CTKB
Business Update
Quanterix Reports Impressive Q4 2024 Revenue Growth of 11%, Outpacing Industry Peers Despite Financial Setbacks,

Quanterix Corporation Reports Strong Financial Growth Amid Industry Challenges: A Q4 2024 Analysis In a notable demonstration of resilience and strategic execution, Quanterix Corporation (NASDAQ: QTRX), a leader in ultra-sensitive biomarker detection, announced its financial results for the fourth quarter of 2024, spotlighting an 11% revenue growth. This ...

Mar 18, 2025 • Laboratory Analytical Instruments Industry
QTRX
Shares
EyePoint Pharmaceuticals Strengthens Employee Incentives with Stock Options Amid Financial Growth and Public Offering Success,

EyePoint Pharmaceuticals Expands Employee Incentives and Strengthens Financial Position Amid Market ActivityWATERTOWN, Mass. March 17, 2025 EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company devoted to the development and commercialization of innovative therapeutics designed to enhance the quality of life for patients affected by serious retinal ...

Mar 17, 2025 • Laboratory Analytical Instruments Industry
EYPT
Shares
Strategic Inducement Grants: Rapid Micro Biosystems Expands Talent Pool Amid Growth Initiatives

On March 12, 2025, Rapid Micro Biosystems, Inc. (Nasdaq: RPID), a pivotal player in the life sciences sector, announced significant inducement grants as part of its strategic growth efforts. The company, headquartered in Lexington, Massachusetts, focuses on developing automation solutions that enhance the manufacturing and release processes for healthcare...

Mar 12, 2025 • Laboratory Analytical Instruments Industry
RPID
Business Update
Revvitys Dual Odyssey Pioneering Measles Diagnostics & Navigating Financial Horizons,

From Virus Vigilance to Financial Resilience: Revvity s Dual Path of Innovation In an era where healthcare precision and profitability walk hand-in-hand, Revvity, Inc. (NYSE: RVTY) strides forward as a formidable player in both arenas. The Massachusetts-based company recently announced a pivotal advancement with its subsidiary, EUROIMMUN, unveiling the CE...

Mar 3, 2025 • Laboratory Analytical Instruments Industry
RVTY
Business Update
Bruker Corporations Mixed Quarter Strategic Advances Amidst ROI Challenges

As the biotechnology landscape continues to evolve, Bruker Corporation finds itself at a crucial juncture. While the company gears up to showcase its groundbreaking advances at the upcoming AGBT 2025 conference, recent financial performance highlights a mixed bag of results. In the third quarter of 2024, Bruker reported a return on average invested assets...

Feb 21, 2025 • Laboratory Analytical Instruments Industry
BRKR
Stock Market Announcement
Talent in Focus: EyePoint Pharmaceuticals Inducement Grants Spur Growth Potential Despite Dilution Risks,

EyePoint Pharmaceuticals Boosts Talent with Inducement Grants: What It Means for InvestorsIn a significant move that reflects its continued commitment to fostering growth and attracting talent, EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) recently announced the granting of non-statutory stock options to new employees as part of their efforts to enhance ...

Feb 17, 2025 • Laboratory Analytical Instruments Industry
EYPT

Decision Framework & Data Access

Power onboarding, benchmarking, and quantitative analysis with institutional-grade datasets structured for direct integration into financial models and risk frameworks.

  • Industry benchmarking datasets (valuation, growth, profitability)
  • Designed for quant models, AML/KYC validation & onboarding workflows
  • Consistent time-series structure (Quarterly, TTM, Annual)
  • Coverage across 100+ industries and 20+ years of history
CSV - SFTP - REST API - Daily Updates - Integration-ready for Python, R & BI tools